Literature DB >> 26003518

The keratocystic odontogenic tumour (KCOT)--an odyssey.

M A Pogrel1.   

Abstract

The most appropriate management for the lesion now known as the keratocystic odontogenic tumour (previously known as the odontogenic keratocyst) remains controversial. This article reviews the different management protocols adopted by one surgical unit over the last 30 years and the results obtained from the different treatment modalities. A current treatment protocol consisting of initial decompression followed by aggressive curettage and peripheral ostectomy with methylene blue staining appears to be successful, but our longest follow-up is only 6 years.
Copyright © 2015 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  keratocystic odontogenic tumour; odontogenic keratocyst; treatment protocols

Mesh:

Year:  2015        PMID: 26003518     DOI: 10.1016/j.ijom.2015.03.008

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  4 in total

Review 1.  Controversies in Odontogenic Tumours: Review.

Authors:  Pooja Siwach; Tabita Joy; Jagdish Tupkari; Arush Thakur
Journal:  Sultan Qaboos Univ Med J       Date:  2017-10-10

Review 2.  An evidence-based surgical algorithm for management of odontogenic keratocyst.

Authors:  Fadekemi Olufunmilayo Oginni; Nasser Alasseri; Oladunni Mojirayo Ogundana; Bamidele Adetokunbo Famurewa; Anthony Pogrel; Essam Ahmed Al-Moraissi
Journal:  Oral Maxillofac Surg       Date:  2022-04-27

3.  Treatment For The Large Aggressive Benign Lesions Of The Jaws.

Authors:  Sirmahan Cakarer; S Cemil Isler; Basak Keskin; Aysenur Uzun; Hulya Kocak Berberoglu; Cengizhan Keskin
Journal:  J Maxillofac Oral Surg       Date:  2017-11-24

4.  Immunohistochemical Characterization of Reactive Epithelial Changes in Odontogenic Keratocysts.

Authors:  Dorottya Cserni; Tamás Zombori; Anette Stájer; Annamária Rimovszki; Gábor Cserni; Zoltán Baráth
Journal:  Pathol Oncol Res       Date:  2019-10-18       Impact factor: 3.201

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.